P. Voet

发表

Characterization of monoclonal antibodies to hepatitis E virus (HEV) capsid protein and identification of binding activity.

D. Vaughn, R. Kuschner, Junkun He, 2007, Journal of biomedical science.

Animal models for meningococcal disease.

J. Poolman, A. Gorringe, P. Voet, 2001, Methods in molecular medicine.

Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults.

Y. Lobet, P. Voet, P. Desmons, 1996, Vaccine.

Function of Neisserial Outer Membrane Phospholipase A in Autolysis and Assessment of Its Vaccine Potential

J. Tommassen, M. Bos, J. V. van Putten, 2005, Infection and Immunity.

Antigenic conservation of an immunodominant invariable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia burgdorferi SL.

Y. Lobet, F. Liang, E. Aberer, 2000, The Journal of infectious diseases.

Simultaneous synthesis and assembly of various hepatitis B surface proteins in Saccharomyces cerevisiae.

E. Jacobs, T. Cabezón, P. Voet, 1989, Gene.

Immunization with a polyvalent OspA vaccine protects mice against Ixodes ricinus tick bites infected by Borrelia burgdorferi ss, Borrelia garinii and Borrelia afzelii.

Y. Lobet, P. Voet, L. Gern, 1997, Vaccine.

Clinical and immunological assessment of a candidate Lyme disease vaccine in healthy adults: antibody persistence and effect of a booster dose at month 12.

P. Voet, C. Van Hoecke, D. de Grave, 1998, Vaccine.

Immunization of mice by recombinant OspA preparations and protection against Borrelia burgdorferi infection induced by Ixodes ricinus tick bites.

P. Hauser, E. Simoen, Y. Lobet, 1994, Immunology letters.

Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant.

W. Carman, H. Thomas, P. Voet, 1992, The Journal of clinical investigation.

Correlation between in vivo humoral and in vitro cellular immune responses following immunization with hepatitis B surface antigen (HBsAg) vaccines.

G. Leroux-Roels, P. Voet, E. van Hecke, 1994, Vaccine.

HepG2 cell binding activities of different hepatitis B virus isolates: inhibitory effect of anti-HBs and anti-preS1(21-47).

C. Dauguet, M. Petit, S. Dubanchet, 1991, Virology.

Plasmodium falciparum: recombinant baculoviruses direct the expression of circumsporozoite proteins in Spodoptera frugiperda cell cultures

P. Gilles, M. Massaer, A. Bollen, 1991, Molecular Biology Reports.

Immunological properties of recombinant HBsAg produced in yeast.

E. Simoen, J. Stéphenne, H. Thomas, 1987, Postgraduate medical journal.

Vaccination of natural reservoir hosts with recombinant lipidated OspA induces a transmission-blocking immunity against Lyme disease spirochaetes associated with high levels of LA-2 equivalent antibodies.

M. Simon, P. Voet, K. Kurtenbach, 1997, Vaccine.

Inhibition of Borrelia burgdorferi-Tick Interactions In Vivo by Outer Surface Protein A Antibody1

Ruth R. Montgomery, S. Malawista, E. Fikrig, 2001, The Journal of Immunology.

Vaccine potential of the Neisseria meningitidis lactoferrin-binding proteins LbpA and LbpB.

J. Tommassen, M. Bos, J. Poolman, 2006, Vaccine.

Industrial implementation of in vitro production of monoclonal antibodies.

Pierre Voet, V. Dewar, P. Voet, 2005, ILAR journal.

Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine.

J. Sadoff, I. Schneider, W. Ballou, 1995, The Journal of infectious diseases.